Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

601 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Completed

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

NCT01227577

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia in Chronic Phase, +11 more
Locations
  • Pacific Cancer Medical Center, Inc. Anaheim, California, United States
  • Providence St. Joseph Medical Center Roy&Patricia Disney Fam Cancer Burbank, California, United States
  • Bay Area Cancer Research Dept.ofBayAreaCancerResearch Concord, California, United States
  • St. Jude Heritage Medical Group Virginia Crosson Cancer Center Yorba Linda, California, United States
View all 32 locations
View Trial Details
Completed

Randomized Phase Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib

NCT00802841

Conditions
Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +22 more
Locations
  • Novartis Investigative Site Caba, Buenos Aires, Argentina
  • Novartis Investigative Site Caba, Buenos Aires, Argentina
  • Novartis Investigative Site La Plata, Buenos Aires, Argentina
  • Novartis Investigative Site Rio Negro, Viedma, Argentina
View all 56 locations
View Trial Details

Related conditions